Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorRouhollah, Khodadust
dc.contributor.authorPelin, Mutlu
dc.contributor.authorSerap, Yalcin
dc.contributor.authorGozde, Unsoy
dc.contributor.authorUfuk, Gunduz
dc.date.accessioned2019-11-24T20:59:04Z
dc.date.available2019-11-24T20:59:04Z
dc.date.issued2013
dc.identifier.issn0022-3549
dc.identifier.urihttps://dx.doi.org/10.1002/jps.23524
dc.identifier.urihttps://hdl.handle.net/20.500.12513/3211
dc.descriptionWOS: 000319071200016en_US
dc.descriptionPubMed ID: 23558592en_US
dc.description.abstractNanotechnology is a promising alternative to overcome the limitations of classical chemotherapy. As a novel approach, dendrimer-coated magnetic nanoparticles (DcMNPs) maintain suitable drug delivery system because of their buildup of functional groups, symmetry perfection, nanosize, and internal cavities. They can also be targeted to the tumor site in a magnetic field. The aim of this study is to obtain an effective targeted delivery system for doxorubicin, using polyamidoamine (PAMAM) DcMNPs. Different generations (G2, G3, G4, and G7) of PAMAM DcMNPs were synthesized. Doxorubicin loading, release, and stability efficiencies in these nanoparticles (NPs) were studied. The results showed that low-generation NPs obtained in this study have pH-sensitive drug release characteristics. G4DcMNP, which releases most of the drug in lower pH, seems to be the most suitable generation for efficient Doxorubicin delivery. Furthermore, application of doxorubicin-loaded G4DcMNPs may help to overcome doxorubicin resistance in MCF-7 cells. On the contrary, G2 and G3DcMNPs would be suitable for the delivery of drugs such as vinca alkaloids (Johnson IS, Armstrong JG, Gorman M, Burnett JP. 1963. Cancer Res 23:13901427.) and taxenes (Clarke SJ, Rivory LP. 1999. Clin Pharmacokinet 36(2):99114.), which show their effects in cytoplasm. The results of this study can provide new insights in the development of pH-sensitive targeted drug delivery systems to overcome drug resistance during cancer therapy. (c) 2013 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 102:18251835, 2013en_US
dc.description.sponsorshipTUBITAKTurkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK) [TBAG-109T949, TBAG-2215]; Middle East Technical UniversityMiddle East Technical University [BAP-07-02-2010-06]en_US
dc.description.sponsorshipThis study was supported by TUBITAK (TBAG-109T949 and TBAG-2215) and Middle East Technical University (BAP-07-02-2010-06).en_US
dc.language.isoengen_US
dc.publisherWILEY-BLACKWELLen_US
dc.relation.isversionof10.1002/jps.23524en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectcanceren_US
dc.subjectPAMAM dendrimer-coated magnetic nanoparticlesen_US
dc.subjecttargeted drug deliveryen_US
dc.subjectdoxorubicinen_US
dc.subjectcontrolled releaseen_US
dc.subjectstabilityen_US
dc.subjectdrug delivery systemen_US
dc.titleDoxorubicin loading, release, and stability of polyamidoamine dendrimer-coated magnetic nanoparticlesen_US
dc.typearticleen_US
dc.relation.journalJOURNAL OF PHARMACEUTICAL SCIENCESen_US
dc.contributor.departmentKırşehir Ahi Evran Üniversitesi, Mühendislik-Mimarlık Fakültesi, Gıda Mühendisliği Bölümüen_US
dc.identifier.volume102en_US
dc.identifier.issue6en_US
dc.identifier.startpage1825en_US
dc.identifier.endpage1835en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster